:max_bytes(133120)/d2j5s05om7evfr.cloudfront.net/pubmed-llm-images/40392453/054c93becf96bf01bb86581699b51346_wm.png)
Therapeutics controversies in antineutrophilic cytoplasmic antibody-associated vasculitis.
Summary: Imagine your body's defense system gets confused and starts attacking your own small blood vessels. This condition is called AAV. For a long time, doctors used very strong drugs and steroids to treat it, but these often caused harsh side effects. Today, there are newer, safer options like a drug called Rituximab. Doctors are also using much lower doses of steroids to help prevent infections. While treatments are getting better, doctors are still debating how long patients should stay on these medicines and when to use special blood-cleaning treatments. Exciting new medicines that target specific parts of the immune system are also showing great promise for the future!
Tags
Vasculitis
Recurrence
Kidney Diseases
Hemorrhage
Disease
Inflammation
Infections
Complement C3
Basement Membrane
Antibodies, Antineutrophil Cytoplasmic
Plasma Exchange
Cyclophosphamide
Glomerular Basement Membrane